CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 16.735
EU - Europa 5.925
AS - Asia 4.343
SA - Sud America 701
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 9
Totale 27.791
Nazione #
US - Stati Uniti d'America 16.593
UA - Ucraina 1.827
SG - Singapore 1.707
CN - Cina 1.140
DE - Germania 1.052
IT - Italia 1.009
HK - Hong Kong 862
FI - Finlandia 710
BR - Brasile 643
RU - Federazione Russa 455
IE - Irlanda 309
SE - Svezia 193
TR - Turchia 185
KR - Corea 135
CA - Canada 108
GB - Regno Unito 100
VN - Vietnam 72
IN - India 59
FR - Francia 53
AT - Austria 41
BE - Belgio 39
BD - Bangladesh 27
NL - Olanda 27
CZ - Repubblica Ceca 26
IQ - Iraq 23
ES - Italia 21
EU - Europa 21
MX - Messico 20
PL - Polonia 17
ZA - Sudafrica 17
AR - Argentina 16
PK - Pakistan 16
IR - Iran 15
JP - Giappone 12
IL - Israele 9
AU - Australia 8
AZ - Azerbaigian 8
MA - Marocco 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
EC - Ecuador 7
JO - Giordania 7
TG - Togo 7
TN - Tunisia 7
CO - Colombia 6
EG - Egitto 5
PE - Perù 5
RO - Romania 5
RS - Serbia 5
TW - Taiwan 5
AM - Armenia 4
EE - Estonia 4
ID - Indonesia 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
LT - Lituania 4
PH - Filippine 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
BT - Bhutan 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
ME - Montenegro 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
Totale 27.786
Città #
Woodbridge 2.091
Fairfield 1.829
Ann Arbor 1.474
Jacksonville 1.305
Houston 1.113
Chandler 975
Ashburn 883
Hong Kong 860
Singapore 860
Dearborn 788
Wilmington 783
Seattle 721
Cambridge 648
Beijing 564
Boardman 431
Princeton 336
Dublin 307
Munich 270
Udine 180
Izmir 161
Hefei 149
San Diego 128
Seoul 124
Helsinki 123
Ottawa 79
Des Moines 74
Milan 73
Ogden 71
Norwalk 64
Dong Ket 53
Nanjing 51
Kunming 49
Redmond 47
São Paulo 47
San Mateo 45
Rome 42
Los Angeles 39
Guangzhou 38
New York 33
Brussels 30
Nuremberg 30
Santa Clara 28
Grafing 25
Falls Church 24
Vienna 23
Brno 22
Shanghai 22
Trieste 21
Düsseldorf 20
Belo Horizonte 19
Turku 19
Washington 19
Jinan 18
San Francisco 17
Warsaw 16
Phoenix 15
Boston 14
Brooklyn 14
Frankfurt am Main 14
Fuzhou 13
London 13
Mcallen 13
Council Bluffs 12
Xi'an 12
Codroipo 11
Goiânia 11
Indiana 11
Nanchang 11
Pignone 11
Rio de Janeiro 11
Secaucus 11
Baghdad 10
Brasília 10
Hebei 10
Hyderabad 10
Wuhan 10
Chicago 9
Dallas 9
Johannesburg 9
Paris 9
Stockholm 9
Turin 9
Andover 8
Ankara 8
Baku 8
Chennai 8
Espoo 8
Mumbai 8
Porto Alegre 8
Saint Petersburg 8
Taranto 8
Vicenza 8
Xian 8
Bitetto 7
Bologna 7
Buffalo 7
Catania 7
Changsha 7
Hangzhou 7
Jyväskylä 7
Totale 18.699
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 245
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 215
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 207
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 178
Aldosterone and the heart: from basic research to clinical evidence 162
Abnormalities of insulin receptors in spontaneously hypertensive rats 159
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 158
Aldosterone and Left Ventricular Remodeling 156
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 147
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 146
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 141
Aldosterone and the heart: still an unresolved issue? 138
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 138
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 137
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 137
Aldosterone, Organ Damage, and Dietary Salt 137
Abnormalities of glucose metabolism in patients with early renal failure 136
The emergent cardiovascular risk factors and organ damage in arterial hypertension 136
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 135
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 134
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 133
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 133
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 132
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 132
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 130
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 130
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 130
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 130
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 129
Prohypertensive effect of insulin: possible role of the sympathetic system 128
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 128
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 128
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 128
Treatment of primary aldosteronism and organ protection 128
Benzodiazepines: an old class of new antihypertensive drugs? 127
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 127
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 125
Kidney in primary aldosteronism: a key determinant of treatment outcome 123
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 123
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 122
Spontaneous restoration of sinus rhythm after cardiac surgery 122
Renal function in primary aldosteronism 121
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 121
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 121
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 121
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 120
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 120
Salt, hypertension, and cardiovascular disease 119
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 119
Benign familial macrocytosis 118
Cardiovascular outcomes in patients with primary aldosteronism after treatment 118
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 117
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 117
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 117
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 117
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 117
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 116
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 116
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 116
Potassium-sparing diuretics in hypertension 115
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 115
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 115
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 114
Diabetes, diabetic complications, and blood pressure targets 114
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 113
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 113
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 112
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 112
The SPARTACUS Trial: Controversies and Unresolved Issues 112
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 111
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 111
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 111
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 109
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 108
Glucose metabolism in early renal failure 108
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 108
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 106
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 106
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 105
Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension 105
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial 105
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 104
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 104
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 104
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 104
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 104
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 104
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 103
Primary hyperparathyroidism in pregnancy 103
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 102
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 102
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 102
Uricaemia and left ventricular mass in hypertensive patients 102
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 102
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 101
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 101
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 101
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 100
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 100
NON-ALCOHOLIC FATTY LIVER DISEASE IS NOT ASSOCIATED WITH VITAMIN D DEFICIENCY IN ESSENTIAL HYPERTENSION 100
Totale 12.332
Categoria #
all - tutte 112.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.703 107 394 93 497 97 497 198 431 642 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/2026383 383 0 0 0 0 0 0 0 0 0 0 0
Totale 28.663